These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


131 related items for PubMed ID: 2721244

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. The Skin Cancer Prevention Study Group.
    Greenberg ER, Baron JA, Stukel TA, Stevens MM, Mandel JS, Spencer SK, Elias PM, Lowe N, Nierenberg DW, Bayrd G.
    N Engl J Med; 1990 Sep 20; 323(12):789-95. PubMed ID: 2202901
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.
    Clark LC, Combs GF, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, Krongrad A, Lesher JL, Park HK, Sanders BB, Smith CL, Taylor JR.
    JAMA; 1996 Dec 25; 276(24):1957-63. PubMed ID: 8971064
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Clinical and laboratory adverse effects associated with long-term, low-dose isotretinoin: incidence and risk factors. The Isotretinoin-Basal Cell Carcinomas Study Group.
    Tangrea JA, Adrianza E, Helsel WE, Taylor PR, Hartman AM, Peck GL, Edwards BK.
    Cancer Epidemiol Biomarkers Prev; 1993 Dec 25; 2(4):375-80. PubMed ID: 8348061
    [Abstract] [Full Text] [Related]

  • 29. Chemoprevention of basal cell carcinoma with isotretinoin.
    Peck GL, Gross EG, Butkus D, DiGiovanna JJ.
    J Am Acad Dermatol; 1982 Apr 25; 6(4 Pt 2 Suppl):815-23. PubMed ID: 6950957
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Xeroderma pigmentosum: a Turkish case series.
    Gül U, Kiliç A, Gönül M, Cakmak SK, Soylu S.
    Int J Dermatol; 2007 Nov 25; 46(11):1125-8. PubMed ID: 17988329
    [Abstract] [Full Text] [Related]

  • 34. The role of dermabrasion and chemical peels in the treatment of patients with xeroderma pigmentosum.
    Nelson BR, Fader DJ, Gillard M, Baker SR, Johnson TM.
    J Am Acad Dermatol; 1995 Apr 25; 32(4):623-6. PubMed ID: 7896953
    [Abstract] [Full Text] [Related]

  • 35. [A whole family affected by xeroderma pigmentosum: clinical and genetic particularities].
    Zghal M, Fazaa B, Zghal A, Mokhtar I, Sarasin A, Kamoun MR, Gharbi MR.
    Ann Dermatol Venereol; 2003 Jan 25; 130(1 Pt 1):31-6. PubMed ID: 12605154
    [Abstract] [Full Text] [Related]

  • 36. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck.
    Hong WK, Lippman SM, Itri LM, Karp DD, Lee JS, Byers RM, Schantz SP, Kramer AM, Lotan R, Peters LJ.
    N Engl J Med; 1990 Sep 20; 323(12):795-801. PubMed ID: 2202902
    [Abstract] [Full Text] [Related]

  • 37. [Xeroderma pigmentosum: report of 6 cases in Dakar].
    Dieng MT, Niang SO, Dangou JM, Ndiaye B.
    Bull Cancer; 2001 Feb 20; 88(2):199-202. PubMed ID: 11257594
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.